[PDF][PDF] Differential molecular response of the transcripts B2A2 and B3A2 to imatinib mesylate in chronic myeloid leukemia

CM de Oliveira, AQ Bentes, AC Beltrão… - Genet Mol Res, 2005 - academia.edu
Chronic myeloid leukemia (CML) originates from the hematopoietic stem cell and is
characterized by the reciprocal translocation t (9; 22)(q34; q11), which results in the BCR …

[PDF][PDF] Differential molecular response of the transcripts B2A2 and B3A2 to imatinib mesylate in chronic myeloid leukemia

JAR de Lemos, CM de Oliveira, ACC Scerni… - Genetics and …, 2005 - academia.edu
Chronic myeloid leukemia (CML) originates from the hematopoietic stem cell and is
characterized by the reciprocal translocation t (9; 22)(q34; q11), which results in the BCR …

[PDF][PDF] Differential molecular response of the transcripts B2A2 and B3A2 to imatinib mesylate in chronic myeloid leukemia

JAR de Lemos, CM de Oliveira, ACC Scerni… - Genet. Mol …, 2005 - funpecrp.com.br
Chronic myeloid leukemia (CML) originates from the hematopoietic stem cell and is
characterized by the reciprocal translocation t (9; 22)(q34; q11), which results in the BCR …

Differential molecular response of the transcripts B2A2 and B3A2 to imatinib mesylate in chronic myeloid leukemia

JA de Lemos, CM de Oliveira, AC Scerni… - Genet. mol. res …, 2005 - pesquisa.bvsalud.org
Chronic myeloid leukemia (CML) originates from the hematopoietic stem cell and is
characterized by the reciprocal translocation t (9; 22)(q34; q11), which results in the BCR …

[PDF][PDF] Differential molecular response of the transcripts B2A2 and B3A2 to imatinib mesylate in chronic myeloid leukemia

JAR de Lemos, CM de Oliveira, ACC Scerni… - Genet. Mol …, 2005 - scholar.archive.org
Chronic myeloid leukemia (CML) originates from the hematopoietic stem cell and is
characterized by the reciprocal translocation t (9; 22)(q34; q11), which results in the BCR …

Differential molecular response of the transcripts B2A2 and B3A2 to imatinib mesylate in chronic myeloid leukemia.

JA de Lemos, CM de Oliveira, AC Scerni… - Genetics and …, 2005 - europepmc.org
Chronic myeloid leukemia (CML) originates from the hematopoietic stem cell and is
characterized by the reciprocal translocation t (9; 22)(q34; q11), which results in the BCR …

Differential molecular response of the transcripts B2A2 and B3A2 to imatinib mesylate in chronic myeloid leukemia

JAR de Lemos, CM de Oliveira… - Genetics and …, 2005 - pubmed.ncbi.nlm.nih.gov
Chronic myeloid leukemia (CML) originates from the hematopoietic stem cell and is
characterized by the reciprocal translocation t (9; 22)(q34; q11), which results in the BCR …

[PDF][PDF] Differential molecular response of the transcripts B2A2 and B3A2 to imatinib mesylate in chronic myeloid leukemia

JAR de Lemos, CM de Oliveira, ACC Scerni… - Genet. Mol …, 2005 - geneticsmr.com
Chronic myeloid leukemia (CML) originates from the hematopoietic stem cell and is
characterized by the reciprocal translocation t (9; 22)(q34; q11), which results in the BCR …

[PDF][PDF] Differential molecular response of the transcripts B2A2 and B3A2 to imatinib mesylate in chronic myeloid leukemia

JAR de Lemos, CM de Oliveira, ACC Scerni… - Genet. Mol. Res, 2005 - Citeseer
Chronic myeloid leukemia (CML) originates from the hematopoietic stem cell and is
characterized by the reciprocal translocation t (9; 22)(q34; q11), which results in the BCR …

[PDF][PDF] Differential molecular response of the transcripts B2A2 and B3A2 to imatinib mesylate in chronic myeloid leukemia

JAR de Lemos, CM de Oliveira, ACC Scerni… - Genet. Mol …, 2005 - funpecrp.com.br
Chronic myeloid leukemia (CML) originates from the hematopoietic stem cell and is
characterized by the reciprocal translocation t (9; 22)(q34; q11), which results in the BCR …